ZW25
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ZW25, covering 2024-08-14 to 2024-11-27. Get the full timeline:
Most recent: Clinical Trial Update: Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers [Phase 1]